MediWound Ltd.

NasdaqGM:MDWD Rapporto sulle azioni

Cap. di mercato: US$188.5m

MediWound Gestione

Gestione criteri di controllo 1/4

MediWound Il CEO è Ofer Gonen, nominato in Jun2022, e ha un mandato di 2.5 anni. la retribuzione annua totale è $ 1.13M, composta da 42.4% di stipendio e 57.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.04% delle azioni della società, per un valore di $ 1.96M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.9 anni e 2.3 anni.

Informazioni chiave

Ofer Gonen

Amministratore delegato

US$1.1m

Compenso totale

Percentuale dello stipendio del CEO42.4%
Mandato del CEO2.5yrs
Proprietà del CEO1.0%
Durata media del management1.9yrs
Durata media del Consiglio di amministrazione2.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Earnings Update: MediWound Ltd. (NASDAQ:MDWD) Just Reported And Analysts Are Trimming Their Forecasts

Nov 29
Earnings Update: MediWound Ltd. (NASDAQ:MDWD) Just Reported And Analysts Are Trimming Their Forecasts

MediWound Is A Healthy Investment

Oct 29

Market Participants Recognise MediWound Ltd.'s (NASDAQ:MDWD) Revenues Pushing Shares 43% Higher

Jul 23
Market Participants Recognise MediWound Ltd.'s (NASDAQ:MDWD) Revenues Pushing Shares 43% Higher

Analysts Have Made A Financial Statement On MediWound Ltd.'s (NASDAQ:MDWD) First-Quarter Report

Jun 01
Analysts Have Made A Financial Statement On MediWound Ltd.'s (NASDAQ:MDWD) First-Quarter Report

Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25%

May 07
Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25%

We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely

Feb 28
We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely

Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking

Feb 01
Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking

MediWound Ltd.'s (NASDAQ:MDWD) 26% Share Price Surge Not Quite Adding Up

Dec 18
MediWound Ltd.'s (NASDAQ:MDWD) 26% Share Price Surge Not Quite Adding Up

MediWound Ltd. (NASDAQ:MDWD) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Sep 29
MediWound Ltd. (NASDAQ:MDWD) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

MediWound's NexoBrid for thermal burns in children gets EMA review

Sep 20

Need To Know: Analysts Just Made A Substantial Cut To Their MediWound Ltd. (NASDAQ:MDWD) Estimates

Aug 11
Need To Know: Analysts Just Made A Substantial Cut To Their MediWound Ltd. (NASDAQ:MDWD) Estimates

MediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $4.67M misses by $0.61M

Aug 09

MediWound refiling for NexoBrid to treat severe thermal burns gets FDA review

Aug 03

MediWound adds 13% after favorable data for ulcer candidate

Jul 07

MediWound taps Tzvi Palash as COO

Jun 30

Is MediWound (NASDAQ:MDWD) In A Good Position To Deliver On Growth Plans?

Jun 24
Is MediWound (NASDAQ:MDWD) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching MediWound's (NASDAQ:MDWD) Cash Burn Situation

Dec 07
Here's Why We're Watching MediWound's (NASDAQ:MDWD) Cash Burn Situation

MediWound: Adjusting My Strategy After NexoBrid CRL

Jul 28

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Ofer Gonen rispetto agli utili di MediWound?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$20m

Mar 31 2024n/an/a

-US$13m

Dec 31 2023US$1mUS$480k

-US$7m

Sep 30 2023n/an/a

-US$12m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022US$850kUS$253k

-US$20m

Compensazione vs Mercato: La retribuzione totale di Ofer ($USD 1.13M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 1.44M ).

Compensazione vs guadagni: La retribuzione di Ofer è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Ofer Gonen (51 yo)

2.5yrs

Mandato

US$1,133,000

Compensazione

Mr. Ofer Gonen, B.Sc. MA Economic & Finance, serves as Chief Executive Officer at MediWound Ltd. since June 30, 2022. He was Chief Executive Officer of Clal Biotechnology Industries Ltd.from March 7, 2017...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Ofer Gonen
Chief Executive Officer2.5yrsUS$1.13m1.04%
$ 2.0m
Hani Luxenburg
Chief Financial Officer1.6yrsUS$244.00kNessun dato
Yaron Meyer
Executive VP11yrsUS$379.00kNessun dato
Ety Klinger
Chief Research & Development Officer10.6yrsUS$479.00kNessun dato
Lior Rosenberg
Co-Founder23.9yrsUS$817.00kNessun dato
Shmulik Hess
COO & Chief Commercial Officerless than a yearNessun datoNessun dato
Liron Gal
Executive Director of Manufacturing Science & Technologyless than a yearNessun datoNessun dato
Barry Wolfenson
Executive Vice President of Strategy & Corporate Development1.8yrsNessun datoNessun dato
Robert Snyder
Chief Medical Officer1.9yrsNessun datoNessun dato

1.9yrs

Durata media

54yo

Età media

Gestione esperta: Il team dirigenziale di MDWD non è considerato esperto (durata media 1.9 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Stephen Wills
Independent Director7.6yrsNessun datoNessun dato
Nachum Shamir
Executive Independent Chairman2.3yrsNessun datoNessun dato
David Fox
Independent Director4.7yrsNessun datoNessun dato
Vickie Driver
Independent Director7.6yrsNessun datoNessun dato
Samuel Moed
Member of Strategic Advisory Board2.2yrsNessun datoNessun dato
Samuel Rubinstein
Independent Director1.3yrsNessun datoNessun dato
John Lantis
Member of Strategic Advisory Board2.2yrsNessun datoNessun dato

2.3yrs

Durata media

70yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di MDWD non è considerato esperto (durata media del mandato 2.3 anni), il che suggerisce un nuovo consiglio.